How Moderna is Rethinking Security Testing in the Age of Autonomous and AI-Driven Attacks

Healthcare security has hit a breaking point. Offense is now autonomous and runs around the clock, yet most defensive programs are still stuck in slow, human led cycles. AI has effectively erased the lag time between a vulnerability being found and being exploited. This makes the old way of doing things, like relying on annual tests and manual checks, completely outdated.

Join a select group of health and life sciences CISOs for a timely discussion on how AI-accelerated vulnerability discovery is reshaping application penetration testing, security risk, and regulatory expectations. As LLMs like Mythos uncover flaws faster than traditional programs can remediate them, CISOs must rethink what “adequate testing” looks like across biotech, pharma, medtech, clinical, and connected-health environments.

Hear from Farzan Karimi, Moderna Deputy CISO, and Nico Waisman, XBOW CISO, on the emerging compliance pressures, operational challenges, and practical steps security leaders can take to protect regulated data, patient safety, intellectual property, and business continuity. This roundtable will help CISOs move beyond annual pentests toward a more defensible, risk-based application security strategy for the AI era.